Sevelamer Carbonate For Suspension
Product Images NDC 64380-880

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 64380-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (F0d25733 65a5 4143 A027 3412ff7a167d 01)

Description (F0d25733 65a5 4143 A027 3412ff7a167d 01)
Chemical structure diagram illustrating the polymeric repeating units of sevelamer carbonate, including ammonium (NH3+) and bicarbonate (HCO3-) groups, along with amine (NH2) and hydroxyl (OH) functional groups, consistent with the active ingredient sevelamer carbonate.*
FDA Label Image

Figure 2 (F0d25733 65a5 4143 A027 3412ff7a167d 02)

Figure 2 (F0d25733 65a5 4143 A027 3412ff7a167d 02)
A subgroup analysis forest plot showing mean differences between Sevelamer Carbonate and placebo across various patient subgroups including screening BSA, baseline serum phosphorus, age, and dialysis status. Each subgroup is represented with a point estimate and 95% confidence interval, indicating whether the results favor Sevelamer Carbonate or placebo.*
FDA Label Image

Figure 2 (F0d25733 65a5 4143 A027 3412ff7a167d 03)

Figure 2 (F0d25733 65a5 4143 A027 3412ff7a167d 03)
A line graph comparing the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL) between Sevelamer Hydrochloride and an active control. The x-axis represents the reduction in serum phosphorus ranging from worsened increase to improved reduction, while the y-axis shows the percentage of patients with reduction greater than or equal to specific values.*
FDA Label Image

Image (F0d25733 65a5 4143 A027 3412ff7a167d 04)

Image (F0d25733 65a5 4143 A027 3412ff7a167d 04)
Line graph depicting phosphorus change from baseline over a 52-week study period comparing Sevelamer Hydrochloride and an Active-Control group. The x-axis represents study weeks, while the y-axis shows phosphorus change values, demonstrating trends in phosphorus levels over time for both treatment groups.*
FDA Label Image

0.8 G Carton (F0d25733 65a5 4143 A027 3412ff7a167d 05)

0.8 G Carton (F0d25733 65a5 4143 A027 3412ff7a167d 05)
Sevelamer Carbonate For Oral Suspension 0.8 g packets in Tutti frutti flavor by Strides Pharma Inc. The carton contains 90 packets. Directions for use instruct emptying the packet into at least 1 ounce of water, stirring, and drinking within 30 minutes. The label includes manufacturer and distributor details and storage instructions.*
FDA Label Image

2.4 G Carton (F0d25733 65a5 4143 A027 3412ff7a167d 06)

2.4 G Carton (F0d25733 65a5 4143 A027 3412ff7a167d 06)
Packaging label for Sevelamer Carbonate For Oral Suspension 2.4 g packets with Tutti frutti flavor by Strides Pharma Inc. The label states it contains 90 packets and is marked as Rx only. Manufacturer is Strides Pharma Science Limited, India, and distributor is Strides Pharma Inc., East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.